FDA Unveils User Fee Hikes To Fund Review Of Drugs, Devices
The U.S. Food and Drug Administration on Thursday unveiled its annual set of user fees paid by drugmakers and medical device companies to fund review of their products, and as usual,...To view the full article, register now.
Already a subscriber? Click here to view full article